UBS’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$37K Buy
4,353
+3,315
+319% +$31.4K ﹤0.01% 7210
2014
Q2
$13K Buy
+1,038
New +$8.42K ﹤0.01% 8657
2014
Q1
Sell
-2,770
Closed -$17.2K 11289
2013
Q4
$13K Buy
2,770
+266
+11% +$1.21K ﹤0.01% 8750
2013
Q3
$17K Buy
+2,504
New +$58.9K ﹤0.01% 8280

Other funds holding RNA

UBS's RNA Position: Q3 2014 in Review

UBS increased its PROSENSA HLDGS N V ORD SHS (NLD) (RNA) stake by 319% in Q3 2014, buying an estimated $31.4K and bringing the position to 4,353 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #7210.

UBS first reported a position in RNA in Q3 2013 and has held it in 4 quarters since. 32 funds tracked by Wall St. Rank hold RNA as of Q3 2014.

  • UBS held 4,353 shares of PROSENSA HLDGS N V ORD SHS (NLD) worth $37K as of Q3 2014.
  • UBS bought 3,315 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q3 2014, an estimated $31.4K.
  • PROSENSA HLDGS N V ORD SHS (NLD) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7210 holding.
  • UBS first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and has held it in 4 quarters since.
  • 32 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.